Boji Medical Technology Co., Ltd Boji Medical Technology Co., Ltd
EN
CN EN
OA系统
Services and Solutions

Pre-Clinical Research

Drug Discovery

Extensive experience across multiple therapeutic areas, end-to-end, customized drug discovery services, and robust custom synthesis capabilities—all accelerating the entire journey of innovative drug development.
Drug Discovery
Clinical Research Services Pre-Clinical Research TCM FC-RS Therapeutic Areas Global New Drug Development Services Ongoing Project Transfer
Drug Discovery Drug Discovery

Drug Discovery
Non-clinical Safety Service Non-clinical Safety Service

Non-clinical Safety Service
Pharmaceutical Development Pharmaceutical Development

Pharmaceutical Development
INTRODUCTION

INTRODUCTION

We provide integrated services encompassing target assessment, molecule design, PCC screening, custom synthesis, and process development—all focused on accelerating projects toward critical decision points and milestones.

With extensive expertise in chronic diseases, oncology, and antiviral therapeutics, we have successfully supported both domestic and international clients in advancing multiple innovative drugs to development.

SERVICES SCOPE

We provide integrated drug discovery services for global pharmaceutical and biotech companies, covering target assessment, PCC validation, and the development of small molecules, nucleic acids, and biologics. Supported by our strong custom synthesis capabilities, we accelerate the entire innovation process for your drug development programs.
01
Target Evaluation
This involves studying the correlation between the biological function of a target and its relevance to disease, conducting comprehensive analyses, benchmarking against competitors to assess strengths and weaknesses, and validating the scientific rationale and feasibility of the project.
02
Drug Design
Leveraging principles of medicinal chemistry alongside cutting-edge tools such as computer-aided drug design (CADD) and AI-driven drug discovery (AIDD), we design novel chemical entities and biotech products with independent intellectual property rights.
03
Structure-Activity Relationship (SAR) Studies
Rapid Synthesis → Activity Screening → Iterative Optimization (supported by custom synthesis of specific intermediates/fragments) to accelerate lead compound discovery.
04
Drug Gability
Lead Compound Optimization and Systematic Drug-Likeness Profiling. This encompasses comprehensive evaluation of biological activity, pharmacokinetic properties, safety profiles, physicochemical characteristics, custom synthesis of impurity/metabolite reference standards, deuterated compound preparation, and ultimately the delivery of a preclinical candidate compound (PCC).
05
Synthesis Process Development
The synthesis process is designed with comprehensive consideration of simplicity, cost-effectiveness, safety, and environmental compatibility. It is subsequently explored and validated, supported by systematic impurity profiling and quality standard development. Process parameters are further optimized through pilot-scale studies to ensure robustness and reproducibility.

OUR ADVANTAGES

  • Seamless Technical Communication – We engage in clear, responsive dialogue and provide molecular structure customization or optimization based on project needs.
  • Scientifically Excellent Delivery – Supported by a comprehensive drug discovery platform and AAALAC accreditation.
  • Robust Intellectual Property Protection – Integrated procedures safeguarding IP throughout drug discovery to clinical.
  • AI‑Enabled Novel Target Drug Discovery – An intelligent workflow enhancing analysis, model desgin, structural screening, and molecular optimization.
  • Stringent Quality Management System – Fully compliant with NMPA, FDA, EMA, and ICH standards.
  • Expert Medicinal Chemistry Team – Over 20 professionals with an average of 10+ years in R&D.

Previous :

Next :

Close